iRepertoire was the first company to develop and commercialize immune repertoire sequencing technology and products.
Over the past decade, iRepertoire has continued to improve our legacy technology, arm-PCR, and developed novel processes and applications. While arm-PCR allows researchers to inclusively amplify all of the expressed V(D)Js in either B or T cells, dam-PCR is the only technology on the market with the ability to profile all 7-adaptive immune chains in the same assay with the inclusion of unique molecular identifiers. Continuing tradition as leaders in the industry, our single cell service, iPair, is the first consumer-based service specifically designed for capturing physically paired variable regions in T cells and B cells.
